Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Concert Pharmaceuticals, Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 14.68||$ 25.04|
|Low||$ 13.8383||$ 12.1579|
The current last sale of $14.31 is 17.70% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical stage biopharmaceutical company applying our extensive knowledge of deuterium chemistry to discover and develop novel small molecule drugs. Incorporation of deuterium into known molecules has the potential to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Our approach starts with approved drugs, advanced clinical candidates or previously studied compounds that may be improved with deuterium substitution. Our technology provides the opportunity to develop products that may compete with the non-deuterated drug in existing markets or to leverage the known activity of approved drugs to expand into new indications. Our DCE Platform® has broad potential across numerous therapeutic areas. The following table summarizes our diverse clinical pipeline of product candidates. All of these candidates are small molecules designed for oral administration. ... More ...
Where does CNCE fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$|
|Quarterly EPS Est:|